Child at Royal Manchester Childrenâs Hospital is first in north to receive £1.79m life-saving gene-therapy drug
Zolgensma is a one-off gene therapy that treats Spinal Muscular Atrophy (SMA).
direct to your inboxInvalid EmailSomething went wrong, please try again later.
Click here
When you subscribe we will use the information you provide to send you these newsletters. Your information will be used in accordance with ourPrivacy Notice.
Thank you for subscribingWe have more newslettersShow meSee ourprivacy notice
A patient at Royal Manchester Childrenâs Hospital is the first in the north of England to receive a potentially life-saving drug on the